Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
gptkb:prucalopride
|
| gptkbp:approvedBy |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:ATCCode |
gptkb:A06AX17
|
| gptkbp:CASNumber |
gptkb:179474-86-7
|
| gptkbp:chemicalFormula |
C18H26N2O4
|
| gptkbp:developedBy |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:hasInChIKey |
QZVZEKDOQGSQPA-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
CC1=CC(=O)N(C2=CC=CC=C12)CCN3CCC(CC3)C(=O)O
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
stimulates colonic peristalsis
|
| gptkbp:molecularWeight |
350.41 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201197
9941576 DB06272 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain headache |
| gptkbp:UNII |
K7V3F8V5CA
|
| gptkbp:usedAs |
serotonin 5-HT4 receptor agonist
|
| gptkbp:usedFor |
treatment of chronic constipation
|
| gptkbp:bfsParent |
gptkb:gabazine
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
SR95531
|